NMR screening methods for drug discovery

Matthew D. Shortridge, Robert Powers

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Drug discovery is a challenging endeavor with a high failure rate. This is further complicated by the fact that each disease has its own unique set of obstacles to developing a safe and effective therapy. Flexible and robust analytical methods are critical for efficiently solving these issues, where nuclear magnetic resonance (NMR) plays an important role in nearly every stage of the drug discovery process. This review will highlight recent developments in the application of NMR as a screening tool for drug discovery that includes: library design, various ligand-affinity screening techniques, rapid determination of protein-ligand co-structures, and the functional annotation of proteins to the discovery of new therapeutic targets.

Original languageEnglish (US)
Title of host publicationBiomolecular NMR Spectroscopy
EditorsAndrew Dingley, Steven Pascal
Pages381-412
Number of pages32
DOIs
StatePublished - Dec 1 2011

Publication series

NameAdvances in Biomedical Spectroscopy
Volume3
ISSN (Print)1875-0656

    Fingerprint

Keywords

  • Drug discovery
  • NMR ligand-affinity screens
  • functional annotation
  • library design
  • rapid co-structures

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Shortridge, M. D., & Powers, R. (2011). NMR screening methods for drug discovery. In A. Dingley, & S. Pascal (Eds.), Biomolecular NMR Spectroscopy (pp. 381-412). (Advances in Biomedical Spectroscopy; Vol. 3). https://doi.org/10.3233/978-1-60750-695-9-381